A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Seagen Inc.
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
AbbVie
Tizona Therapeutics, Inc
Genentech, Inc.
Normunity AccelCo, Inc.
Eli Lilly and Company
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Eli Lilly and Company
Orano Med LLC
Eli Lilly and Company
Fusion Pharmaceuticals Inc.
Innate Pharma
OncoNano Medicine, Inc.
Risen (Suzhou) Pharma Tech Co., Ltd.
Radiopharm Theranostics, Ltd
Therorna
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
Rondo Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Chongqing Precision Biotech Co., Ltd
Kortuc, Inc.
Nurix Therapeutics, Inc.
Pfizer
Arcus Biosciences, Inc.
Adcentrx Therapeutics
Incyte Corporation
AstraZeneca
NextPoint Therapeutics, Inc.
HC Biopharma Inc.
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Exelixis
Seagen Inc.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Symphogen A/S
Vincerx Pharma, Inc.
AstraZeneca
Astellas Pharma Inc
Molecular Templates, Inc.